Should You Take the Startup Equity Package or the Big Company Salary and How Do You Decide?

Should You Take the Startup Equity Package or the Big Company Salary and How Do You Decide?

A candidate named Chris called me last week. Two offers. Same title. Completely different companies.

Medtronic: Territory Manager, Spine division. $82K base, guaranteed bonus structure, full benefits, company car.

A cardiology device startup: Territory Manager. $68K base, equity package (the recruiter said "could be worth millions"), minimal benefits, no car.

"Which one should I take?" Chris asked.

I've had this exact conversation fifty times. The answer is always the same: it depends on who you are.

Last year, three candidates made similar choices. All had offers from big medical device companies and startups.

One picked the startup for the equity. The startup failed. Lost his job. Equity worth zero.

One picked the big company for stability. Bored out of his mind after two years. Wishes he'd taken the risk.

One picked the startup and it worked. Startup got acquired. His equity made him $340K.

Let me show you what happened to each of them.

For medical device company selection guidance, visit RepPath.

Dan: Picked Startup, Startup Failed, Equity Worth Zero

Dan had offers from Stryker (trauma implants, $78K base) and a surgical robotics startup ($62K base plus equity).

"The startup recruiter says my equity could be worth $500K if they IPO," Dan told me, excited.

"What if they don't IPO?" I asked.

"They're Series B funded," Dan said confidently. "They have backing. They're going to succeed."

Dan was 28. Single. No kids. No mortgage. He could afford the risk.

"If you can handle losing the equity entirely, take the startup," I told him. "But understand that most startups fail. The equity might be worth nothing."

"I can handle it," Dan said.

Dan took the startup job.

Year one was exciting. Dan was learning fast. Building the sales process from scratch. Working directly with the CEO and product team.

"I'm not just a cog," Dan told me. "I'm helping build this company."

Year one, Dan made $68K total. Less than Stryker would have paid. But he was happy.

Year two, things changed. The company missed its FDA approval timeline. Twice. Investors got nervous.

"We're running out of cash," Dan called me worried. "They're talking about another funding round. But if we don't get it, we might shut down."

The funding round fell through. The company shut down.

Dan lost his job. His equity was worth zero.

"I knew the risk," Dan told me. "But it still sucks. Two years of work. The equity I was excited about is completely worthless."

Dan got hired at Zimmer Biomet (orthopedics). Back to a stable big company. Making $84K now.

"I don't regret trying the startup," Dan said. "But I learned I'm not cut out for that much uncertainty. Next time, I'll pick stability."

Learn about medical device company selection at RepPath Academy.

Brian: Picked Big Company for Stability, Regrets It

Brian was different. He had offers from Johnson & Johnson (surgical devices, $85K base) and a cardiovascular device startup ($65K base plus equity).

"I have a mortgage and two kids," Brian told me. "I can't risk the startup. I need the stable paycheck."

Brian picked J&J. Higher base salary. Better benefits. Job security.

Year one, Brian was fine. Learning the products. Building his territory. Making $102K with bonuses.

Year two, Brian was bored.

"Everything moves so slow," Brian complained. "I submitted a pricing request three months ago. Still waiting for approval. The bureaucracy is killing me."

Brian also felt like a small cog in a giant machine.

"I'm selling one product line," Brian said. "That's it. I have no influence on anything. No visibility to leadership. I'm just a rep."

Year three, Brian called me.

"That cardiovascular startup I turned down?" Brian said. "They just got acquired by Boston Scientific. The sales rep who took the job I didn't take made $280K from his equity."

Brian was crushed.

"I picked stability," Brian said. "But now I realize I gave up the opportunity of a lifetime. I'd have been fine taking the risk. My wife has a good job. We could have handled it."

Brian's still at J&J. Making $115K now. Good money. But kicking himself.

"I played it safe," Brian said. "That was the right choice for my family at the time. But I'll always wonder what could have been."

Sarah: Picked Startup, It Got Acquired, Made $340K from Equity

The third candidate, Sarah, had offers from Medtronic (neuromodulation, $80K base) and a diabetes device startup ($64K base plus equity).

"What do you think?" Sarah asked me.

"Can you afford the risk?" I asked.

"I'm 31, single, no debt," Sarah said. "I have six months' expenses saved. If the startup fails, I can find another job."

Sarah also did her homework.

"I researched the founders," Sarah explained. "They sold their last company for $150 million. The investors are legit. The technology has FDA breakthrough designation. It's risky, but it's not crazy."

Smart. Sarah wasn't just chasing equity. She vetted the opportunity.

Sarah took the startup.

Year one was hard.

"I'm working way more than I did at my last company," Sarah told me. "Weekends. Late nights. We're building everything from scratch. It's exhausting."

Year one, Sarah made $72K total. Less than Medtronic.

But Sarah loved the work.

"I'm not just selling," Sarah said. "I'm helping design the sales process. Training new reps. Working directly with the CEO on strategy. I feel like I matter."

Year two, the startup raised another funding round. Sarah got more equity in the raise.

Year three, Boston Scientific acquired the startup.

Sarah's equity payout: $340K after taxes.

"I can't believe it worked," Sarah called me, excited. "Three years of hard work. Lower salary. But now I have more money than I've ever had."

Sarah took a senior territory manager role at Boston Scientific (part of the acquisition). Now making $125K base with the potential for more equity.

"The startup paid off," Sarah told me. "But it was risky. If the acquisition hadn't happened, my equity would be worth way less. I got lucky with the timing."

Meet with coaches who help with company selection decisions at Meet Your RepPath Coach.

What Actually Determines Startup vs. Corporate Success

After counseling Dan (startup failed), Brian (regrets big company), Sarah (startup acquired), and dozens of other company selection decisions, here's what actually matters:

Risk tolerance determined by personal financial situation. Dan 28 single no kids/mortgage could afford risk, took startup, failed lost job equity zero but "don't regret trying, learned not cut out for that much uncertainty." Brian mortgage 2 kids couldn't risk startup, picked J&J stability, regrets it when startup acquired other guy made $280K. "Played safe right for family, but always wonder." Sarah 31 single no debt 6 months saved could afford risk, startup acquired $340K equity. Personal finances determine if can handle startup failing.

Startup due diligence matters more than just equity promise. Dan excited "$500K if IPO" didn't vet deeply enough, startup missed FDA timeline 2x ran out of cash shut down. Sarah researched founders (sold last company $150M), investors legit, FDA breakthrough designation. "Risky but not crazy." Sarah's homework paid off. Dan's excitement didn't.

Big company boredom real for entrepreneurial personalities. Brian year 2 bored (everything slow, pricing request 3 months no approval, bureaucracy killing). "Selling one product. No influence. No visibility. Just a rep." Stable job but unfulfilling for his personality. Some people need big company structure, others need startup autonomy/impact.

Startup equity timing is luck. Sarah worked hard 3 years lower salary but acquisition timing made equity $340K. "If acquisition hadn't happened, equity worth way less. Got lucky with timing." Dan's startup shut down before any liquidity event, equity worthless. Equity only valuable if company succeeds AND timing right.

"Boring but stable" vs. "exciting but risky" personality fit. Brian picked J&J stability for family, bored year 2, wishes took risk in retrospect. Sarah picked startup despite lower pay because "feel like I matter, working directly with CEO, designing sales process." Dan loved startup year 1 ("not just cog, helping build") but couldn't handle shutdown uncertainty. Know yourself: need stability or crave impact/autonomy?

Different outcomes from similar decisions:

  • Dan (startup failed): Risk-tolerant chose startup, failed, equity zero, learned needs more stability. Back at big company happy. "Don't regret trying."
  • Brian (big company regret): Risk-averse chose big company, stable/bored, regrets when alternate path succeeded. "Always wonder what could have been."
  • Sarah (startup succeeded): Risk-tolerant + due diligence chose startup, worked hard, acquisition $340K equity. "Got lucky with timing."

What You Should Ask Before Choosing

Don't be Dan gambling without due diligence. Don't be Brian playing it safe and regretting it.

Dan excited about equity didn't vet deeply. Startup missed FDA deadlines, ran out of cash, shut down. Equity zero. "Knew the risk but still sucks. 2 years work, equity worthless." Back at Zimmer stable. "Learned not cut out for that much uncertainty."

Brian picked J&J because mortgage/kids needed stability. Year 2 bored, year 3 crushed when startup he rejected got acquired (other guy $280K). "Played safe right for family but always wonder." Still at J&J kicking himself.

Sarah vetted founders/investors/tech deeply, could afford risk, startup acquired $340K. "Can't believe it worked. But was risky. Got lucky with timing."

Before choosing between startup and big company, ask honestly:

Can you actually afford the startup failing? Dan single no debt could afford risk. Brian mortgage 2 kids couldn't. Sarah 6 months expenses saved could. If startup fails (most do), can you handle being unemployed with worthless equity? If not, take big company.

Are you vetting the startup deeply or just excited about equity? Sarah researched founders (track record), investors (legit), technology (FDA breakthrough). Dan excited "$500K" didn't vet as well. Startup equity promise meaningless if company fails. Do the homework: founders' track record? Investors' quality? Regulatory pathway realistic? Funding runway?

Do you need stability or autonomy/impact? Brian bored big company (slow/bureaucratic/no influence/"just a rep"). Would have thrived at startup. Sarah loved startup (helping design process/working with CEO/"feel like I matter"). Dan loved startup year 1 but couldn't handle uncertainty when failing. If need structure/predictability, big company. If need autonomy/visible impact, startup.

Are you okay with equity being luck? Sarah worked hard but "got lucky with timing" when acquisition happened year 3. Dan worked hard but startup failed before liquidity. Equity only pays if company succeeds AND timing aligns. Can you accept working years for equity that might be zero?

Can you afford lower salary short-term? Sarah $64K year 1 vs. Medtronic $80K. Dan $62K vs. Stryker $78K. Brian $85K J&J couldn't take $20K pay cut. Startups pay less with equity promise. Can you live on lower base while equity vests/appreciates?

"Knew the risk but still sucks," Dan said. "Don't regret trying. Learned needs more stability."

"Played safe right for family," Brian said. "But always wonder what could have been."

"Got lucky with timing," Sarah said. "If acquisition hadn't happened, equity worth way less."

Ready to decide between startup and big company? Contact RepPath or meet with a coach who helps with medical device company selection.

Learn more about navigating medical device company choices at RepPath Academy.

Related Resources

Keep going with RepPath

Reserve My Spot in RepPath Academy →

Back to blog